doxorubicin

TERMINATED · PHASE3 · Acute Lymphoblastic Leukemia

Terminated by IRB for continuing review

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.